Premium
Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis
Author(s) -
Chatterjee Anjan,
Louis Elan D.,
Frucht Steven
Publication year - 2002
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.10118
Subject(s) - levetiracetam , choreoathetosis , medicine , epilepsy , antiepileptic drug , anesthesia , pediatrics , psychiatry , dystonia
Anticonvulsants are frequently used in the treatment of paroxysmal kinesiogenic choreoathetosis (PKC). Although they are often extremely effective in eliminating paroxysmal movements, short‐ and long‐term side‐effects may limit their use in young patients. Levetiracetam (Keppra), a novel antiepileptic drug approved for the treatment of partial seizures is well tolerated in patients with epilepsy. We report on the use of levetiracetam in the treatment of PKC. Levetiracetam was effective in eliminating paroxysmal events and should be considered as an alternative to standard antiepileptic medications in this disorder. © 2002 Movement Disorder Society